Connect with us

Featured

Apple Visits Supreme Court To Help RBG With iPhone X

Daniel Chase

Published

on

stock_price_apple

I think everyone can agree that 2008 was a much simpler time to exist in the world. Sure, the world was suffering from the worst financial crisis since the great depression, with banks getting bailed out left and right, but amid the chaos and jetsam, a beautiful new realm of technology was born, and she was beautiful. In July of 2008, Apple (AAPL) launched the App Store, the first mobile marketplace for developers to conceptualize, build, and offer to consumers mobile applications for new iPhones. Apple (AAPL) went from no apps to hundreds of them overnight, and for the first time, iPhone users had a centralized place to safely purchase and download apps. After ten years of bitmojis, Tinder, and selfies posted on Instagram (FB), I feel comfortable saying that any issue, interest, or project in your life can be paired with an app offered by Apple’s (AAPL) App Store.

 And this, my friends, is where our story begins…

Though the App Store has been revered for its ease of use, in terms of the user experience for consumers, iPhone users cannot download mobile applications from anywhere other than Apple’s own marketplace. Apple (AAPL) does not allow the use of third-party applications on its iOS devices, effectively forcing its customers to use the App Store. In addition to this digital stranglehold, while app developers set their prices for their apps, Apple (AAPL) takes 30% commission on each paid download. 

If you think Apple (AAPL) taking a third of the profits from app developers seems hefty, the company’s terms and conditions for developers selling on the App Store prevents developers from selling their apps on any other marketplaces. Many see these conditions as enabling Apple (AAPL) to create a monopoly for app distribution. Following a lawsuit filed in 2011 against Apple (AAPL) for its alleged unfair monopolization, the company decided to take its case to the US Supreme Court to end the antitrust lawsuit. 

According to CNBC, the case hinges on how the Supreme Court justices will apply one of the court’s past decisions to the claims made against Apple (AAPL). The last related ruling, from 1977, “limited damages for anti-competitive conduct to those directly overcharged rather than indirect victims who paid an overcharge passed on by others.” Legal jargon aside, the 1977 ruling states that the only individuals who can collect damages from antitrust claims are those who were “directly overcharged.” 

This language is key because, until recently, App Store users hadn’t been considered direct purchasers, because Apple (AAPL) claims it only acted as the middle-man between the consumer and the developer. Last year, the San Francisco-based 9th U.S. Circuit Court of Appeals found that Apple (AAPL) was a distributor which sold products, and most importantly, iPhone Apps directly to consumers. 

“Apple’s intentionally closed system prevents competition which enables the App Store to collect a higher price than if Apple were forced to entice the app seekers in a competitive market.”

David Frederick, Legal Counsel for Plaintiffs

As both sides of the case throw their arguments at the mercy of the Supreme Court, the issue is substantially more straightforward than either side realizes. Antitrust lawsuits pertaining to monopolies can only be contested by the direct purchaser, and the justices will have to decide whether Apple (AAPL) is a direct distributor to consumers or if App Store developers are the only people able to sue for antitrust damages. 

Legal experts have pointed out that Monday’s supreme court hearing will not have a massive immediate impact on the day-to-day operations of the App Store, but it may serve as a wakeup call for tech consumers who feel inadvertently forced into purchasing certain products and services when they buy from different companies. 

Continue Reading
Click to comment

Biotechnology

Biotech Names To Know In November 2019

A. Lawrence

Published

on

best biotechnology stocks to buy sell

Biotech Stocks Have rallied since The End Of September; What’s Next?

Over the years, the biotech sector has become one of the fastest-growing sectors in the stock market and naturally, investors are keen to get hold of stocks that could follow a similar growth trajectory. However, just because a sector is growing does not mean that an investor can bet on any stock and hope to make decent returns.

In order to choose the right stock, he needs to do a lot of personal research and watch the market closely. Here is a look at three biotech stocks that investors should track closely owing to recent developments.

Sernova Corp’s (TSX:SVA) (OTC:SEOVF)

Sernova’s therapeutic approach to regenerative medicine focuses on providing direct cell therapies where the cells, transplanted within an organ-like vascularized implantable device, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

The company’s Cell Pouch is a novel, proprietary, scalable, implantable macro-encapsulation device designed for the long- term survival and function of therapeutic cells. At the end of October Sernova Corp. (SVA) (SEOVF) detected enduring levels of C-peptide in the bloodstream of a fasting patient in its continuing phase I/II Cell Pouch United States clinical study of type-1 diabetes. This C-peptide is a biomarker of transplanted beta-cell insulin production,

Why is this important? According to Dr. Piotr Witkowski, Director of Pancreatic, and Islet Transplant Program at the University of Chicago, “Along with the preliminary safety and early indicators of efficacy, I am excited that we are observing C-peptide levels in the patient’s bloodstream after recent transplant, not only following stimulation with a meal but also when the patient is fasting. These findings represent progress in clinical outcomes and evidence of enduring islet survival and function within Sernova’s Cell Pouch.”

Read This Full Press Release Here

Genprex (GNPX)

The first one to put in the watch list is that of Genprex Inc (NASDAQ:GNPX). On Tuesday, the company revealed preclinical data from its study of its product TUSC2 immunogene therapy. The product in question is meant for raising the effectiveness of chemotherapy and anti-PD1 in people suffering from metastatic lung cancers.

The data proved to be positive and that has naturally resulted in a rally in the stock. It is a significant development for Genprex and could potentially help the company in cornering an important portion of the gene therapy market. Hence, it is hardly a surprise that the stock has rallied by as much as 60% after hitting a session’s high of $1.09.

 Can Fite Biopharma (CANF)

The other biotech stock that has made a strong move is the Can Fite Biopharma (NYSE:CANF) stock. The biotech company announced this morning that one of its products, which is meant for the treatment of liver diseases and cancer, has been granted a patent as a sexual dysfunction medicine.

The patents have been granted by the relevant authorities in Canada, Israel, and South Korea. In addition to that, the company has also been awarded patents in Japan, China, United States, Australia, and Hong Kong. It is a highly important development for Can-Fite and it was no surprise when the stock rallied this morning. It has rallied by 3% on Tuesday on the back of the news.

top biotech stocks to watch list

Disclaimer: Pursuant to an agreement between Midam Ventures LLC and Sernova (TSX:SVA) (OTC:SEOVF), Midam has been paid $350,000 for a period from September 23, 2019 to September 22, 2020. We may buy or sell additional shares of Sernova (TSX:SVA) (OTC:SEOVF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Sernova (TSX:SVA) (OTC:SEOVF). Click Here For Full Disclaimer.

Continue Reading

Entertainment

Is The Entertainment Streaming Market Ready For Its Next Move?

A. Lawrence

Published

on

streaming wars netflix apple hulu disney

New Streaming Options Have Opened A Big Door For Content Providers

As many experts have pointed out, the end of 2019 is going to see the commencement of the ‘streaming wars’ as more and more companies enter the OTT market to challenge the supremacy of Netflix Inc (NASDAQ:NFLX). The launch of the streaming service Disney Plus last week formally launched the streaming wars.

Do Content Providers Stand To Benefit?

According to an article published on Reuters the global video streaming market was valued at $26.27 billion in 2015 and is expected to reach $83.41 billion by 2022 growing at a CAGR of 17.9% from 2015 to 2022. Apple, Disney, Netflix, Amazon, NBC, Hulu & more are all competing within the global video streaming market and they all need the same thing… new & original content. Massive demand may create a huge opportunity for companies like Fearless Films (FERL).

Fearless Films is an independent full-service production company. This is the exact type of company that can benefit from what could become one of the biggest cash grabs in entertainment history and here’s why. You’ve likely heard of the big production houses: Warner Bros, DreamWorks, Red Crown Productions and others who benefited from big deals with streaming companies.

It isn’t just Netflix who’s flexing billions in content budgets, Apple, Amazon, Disney, NBC, Roku – the list goes on. These are huge entertainment distributors who are now fighting for one thing… Where you spend your waking hours streaming entertainment.

Click To Read More On Fearless Films (FERL)

Key Analysis On Streaming Service Providers

Considering the fact that the new service has already garnered 10 million users, it’s fair to say that it is here to say. Considering the fact that Apple has already launched its own service and many other services are going to be launched in the next few months, experts are now wondering whether the streaming space has become too crowded.

The success of Game of Thrones has ushered in an era of unprecedented spending for quality content. The show generated total profit to the tune of $2.2 billion for HBO, which is owned by AT&T. Hence, video streaming companies have also decided to spend jaw-dropping sums on original content. Apple has earmarked $6 billion for original content, while Disney is expected to match that.

streaming cord cutting entertainment stocks

Both companies are trying to create that one show that could turn into a cash cow. On the other hand, Apple is going to price is monthly subscription at $4.99 and Disney is going to charge $6.99 for the same. In such a situation, one can expect Netflix to change tack since its cheapest subscription is worth $12.99.

So, the crowding is quite apparent as mega corporations enter the streaming space. However, the question remains whether the business is going to grow and new subscribers are going to flock in. Studies suggest that it will grow and up until 2024, the streaming market should grow by 18.8% each year. In 2024, the market is going to be worth $687 billion. Hence, it is quite clear that despite the intense competition that is going to come to the streaming space, there is still room for companies to grow and become profitable.

apple tv cord cutting AAPL stock

Disclaimer: Pursuant to an agreement between Midam Ventures LLC and Fearless Films Inc. (FERL), Midam has been paid $94,980 by Fearless Films Inc. (FERL) for a period from October 1, 2019 to November 17, 2019. We may buy or sell additional shares of Fearless Films Inc. (FERL) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Fearless Films Inc. (FERL). Click Here For Full Disclaimer.

Continue Reading

Featured

Stock Price Newsletter – November 20, 2019

Daniel Chase

Published

on

best stocks to buy

The Biotech Index Just Hit New Highs; Stocks To Watch

Investment experts and professional money managers almost always tell people to invest across a range of experts. This is usually in order to generate bigger returns in the long term. One of the sectors that is almost always favored by professionals is the biotech sector and the simple reason behind that is the fact that the sector has managed to grow at an impressive pace.

Click To Read More


What Does The Disney (DIS) Plus, Amazon Deal Mean For Investors?

During the company’s conference call for the fourth-quarter earnings, the Chief Executive Officer of Disney Bob Iger stated that the streaming serving Disney+ is going to be available on Amazon Fire TV.

Continue Reading


The $40 Billion Dollar Content Gold Rush

Apple, Disney, Netflix, Amazon, NBC, Hulu & More are All Competing Within the Global Video Streaming Market and They All Need the Same Thing… New & Original Content! Massive Demand May Create Huge Opportunity for One Company!

See For Yourself

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com